# Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa

> **NCT02598466** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 69 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT02598466
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2016-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598466, "Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02598466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*